Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trials.
Kimball, Alexandra B, Murali Sundaram, Alan L Shields, Stacie Hudgens, Martin Okun, Catherine Foley, and Arijit Ganguli. 2018. “Adalimumab Alleviates Skin Pain in Patients With Moderate-to-Severe Hidradenitis Suppurativa: Secondary Efficacy Results from the PIONEER I and PIONEER II Randomized Controlled Trials.”. Journal of the American Academy of Dermatology 79 (6): 1141-43.